Integral Derivatives’s Bristol-Myers Squibb BMY Stock Holding History

Integral Derivatives’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-20,436	Closed	-$1.11M	–	1095
2017 Q1	$1.11M	Buy	+20,436	New	+$1.12M	0.02%	492
2016 Q4	–	Sell	-28,303	Closed	-$1.55M	–	1137
2016 Q3	$1.53M	Buy	+28,303	New	+$1.82M	0.03%	331
2016 Q2	–	Sell	-4,652	Closed	-$329K	–	954
2016 Q1	$297K	Buy	+4,652	New	+$293K	0.01%	637
2014 Q4	–	Sell	-21,338	Closed	-$1.2M	–	1375
2014 Q3	$1.09M	Sell	21,338 -21,576	-50%	-$1.08M	0.02%	671
2014 Q2	$2.08M	Buy	42,914 +16,996	+66%	+$838K	0.04%	405
2014 Q1	$1.35M	Buy	25,918 +17,193	+197%	+$915K	0.03%	556
2013 Q4	$464K	Buy	+8,725	New	+$444K	0.01%	1065

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Integral Derivatives's BMY Position: Q2 2017 in Review

Integral Derivatives sold out of Bristol-Myers Squibb (BMY) in Q2 2017, closing a stake of 20,436 shares — an estimated $1.11M sold.

Integral Derivatives first reported a position in BMY in Q4 2013 and held it in 7 quarters. The position peaked at $2.08M in Q2 2014. 1,595 funds tracked by Wall St. Rank hold BMY as of Q2 2017.

Integral Derivatives reported no remaining Bristol-Myers Squibb position as of Q2 2017 after selling out during the quarter.
Integral Derivatives sold 20,436 Bristol-Myers Squibb shares in Q2 2017, an estimated $1.11M.
Integral Derivatives first reported a position in Bristol-Myers Squibb in Q4 2013 and held it in 7 quarters.
Integral Derivatives's Bristol-Myers Squibb position peaked at $2.08M in Q2 2014.
1,595 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2017.

Based on Integral Derivatives's 13F filing for Q2 2017, filed 14 Aug 2017.